![IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Science Translational Medicine IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abd2223/asset/19ceee17-9a01-455e-a3f9-91447c3a50e6/assets/graphic/abd2223-f1.jpeg)
IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Science Translational Medicine
![Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade - eBioMedicine Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade - eBioMedicine](https://www.thelancet.com/cms/asset/932e4e98-2137-443e-a4b0-942fb7cc8597/gr1.jpg)
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade - eBioMedicine
![Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells - ScienceDirect Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121002032-fx1.jpg)
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells - ScienceDirect
![Frontiers | Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort Frontiers | Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort](https://www.frontiersin.org/files/Articles/829665/fimmu-13-829665-HTML/image_m/fimmu-13-829665-g001.jpg)
Frontiers | Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
![Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection - eClinicalMedicine Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection - eClinicalMedicine](https://www.thelancet.com/cms/attachment/17b20a5b-68af-4351-8bea-68fe7bfefdac/gr2_lrg.jpg)
Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection - eClinicalMedicine
![Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study - The Lancet Healthy Longevity Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/53df1219-ef81-4be7-9e58-949baca55d1a/gr1_lrg.jpg)
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study - The Lancet Healthy Longevity
![Cells | Free Full-Text | Hymenoptera Venom Immunotherapy: Immune Mechanisms of Induced Protection and Tolerance Cells | Free Full-Text | Hymenoptera Venom Immunotherapy: Immune Mechanisms of Induced Protection and Tolerance](https://www.mdpi.com/cells/cells-10-01575/article_deploy/html/images/cells-10-01575-g002.png)
Cells | Free Full-Text | Hymenoptera Venom Immunotherapy: Immune Mechanisms of Induced Protection and Tolerance
![A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-18450-4/MediaObjects/41467_2020_18450_Fig1_HTML.png)
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications
![The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study - The Lancet Microbe The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study - The Lancet Microbe](https://www.thelancet.com/cms/attachment/8820d58a-2023-4025-a890-8e4e748d7dab/gr1_lrg.jpg)
The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study - The Lancet Microbe
![Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies | Molecular Pharmaceutics Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00919/asset/images/medium/mp2c00919_0004.gif)
Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies | Molecular Pharmaceutics
![Pharmaceutics | Free Full-Text | Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein ... Pharmaceutics | Free Full-Text | Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein ...](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-14-01843/article_deploy/html/images/pharmaceutics-14-01843-g003.png?1662601807)